Genocea Biosciences Price on February 24, 2023

GNCADelisted Stock  USD 0.0002  0.0001  100.00%   
If you're considering investing in Genocea Stock, it is important to understand the factors that can impact its price. As of today, the current price of Genocea Biosciences stands at 0.0002, as last reported on the 30th of November, with the highest price reaching 0.0002 and the lowest price hitting 0.0001 during the day. We have found thirty technical indicators for Genocea Biosciences, which you can use to evaluate the volatility of the firm. Please check out Genocea Biosciences' Downside Deviation of 69.7, risk adjusted performance of 0.1626, and Market Risk Adjusted Performance of (3.14) to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Genocea Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
GNCA
Based on monthly moving average Genocea Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genocea Biosciences by adding Genocea Biosciences to a well-diversified portfolio.

Genocea Biosciences Valuation on February 24, 2023

It is possible to determine the worth of Genocea Biosciences on a given historical date. On February 24, 2023 Genocea was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 2.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Genocea Biosciences stock. Still, in general, we apply an absolute valuation method to find Genocea Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Genocea Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Genocea Biosciences' related companies.
 Open High Low Close Volume
  0.0003    0.0003    0.0003    0.0003    1.00  
02/24/2023
  0.0001    0.0002    0.0001    0.0002    33,228  
  0.0001    0.0002    0.0001    0.0002    0.00  
Backtest Genocea Biosciences  |  Genocea Biosciences History  |  Genocea Biosciences Valuation   PreviousNext  
Open Value
1.0E-4
2.0E-4
Closing Value
0.00
Upside

Genocea Biosciences Trading Date Momentum on February 24, 2023

On November 30 2024 Genocea Biosciences was traded for  0.0002  at the closing time. The top price for the day was 0.0002  and the lowest listed price was  0.0001 . There was no trading activity during the period 0.0. Lack of trading volume on November 30, 2024 did not cause price change. The overall trading delta against the current closing price is 50.00% .

Genocea Biosciences Fundamentals Correlations and Trends

By evaluating Genocea Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Genocea Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Genocea financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Genocea Biosciences Stock history

Genocea Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Genocea is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Genocea Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Genocea Biosciences stock prices may prove useful in developing a viable investing in Genocea Biosciences
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Genocea Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 74 people.

Genocea Biosciences Stock Technical Analysis

Genocea Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Genocea Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Genocea Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Genocea Biosciences Period Price Range

Low
November 30, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Genocea Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Genocea Biosciences November 30, 2024 Market Strength

Market strength indicators help investors to evaluate how Genocea Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genocea Biosciences shares will generate the highest return on investment. By undertsting and applying Genocea Biosciences stock market strength indicators, traders can identify Genocea Biosciences entry and exit signals to maximize returns

Genocea Biosciences Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Genocea Biosciences' price direction in advance. Along with the technical and fundamental analysis of Genocea Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Genocea to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in Genocea Stock

If you are still planning to invest in Genocea Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genocea Biosciences' history and understand the potential risks before investing.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Money Managers
Screen money managers from public funds and ETFs managed around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories